Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Dec 13, 2023 9:08pm
230 Views
Post# 35783562

RE:RE:RE:RE:Idle Evening Thoughts

RE:RE:RE:RE:Idle Evening Thoughts
I mentioned previously that I did not think that MC would exercise the options as he would have to follow canadafans rule and never sell a share and there is no way he wants to lay out that cash and hang on to the shares when he can have free options handed at the same time his other ones expire. BTW we are the ones that voted last round so they could have an over allotment of the options for supposedly for the retention of important people in the company. It was almost as if the sp had been walked down to help justifying that they would not have to exercise the stock and so much easier to give up a little profit and get a new boatload of options then to buy shares and hang on to them. Sure took care of the shareholders there but then we do not yet know for sure if anything was exercised but should know within the next week or so.
And canadafan, please next time you post something please do a little research before you tell everyone something that we do not know is true and expect everyone to believe it as gospel. As stated by others and even you if you had looked it was stated that MC was granted 350,000 and no where does it say that any of them were exercised.
And as for people coming and going in a company, you make it sound like it was nothing, Andrew was the head of BD for the company and you think it does not deserve an explanation to the shareholders. What, does the company not have to be accountable for anything to the shareholders. MY god man he was just awarded 350,000 options for a stock that is down 80% and basically tripled managment compensation since the new management took over and you think this is all good.
<< Previous
Bullboard Posts
Next >>